The mutated in colorectal cancer (MCC) gene can serve as a potential biomarker of glioblastoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Mutated in colorectal cancer (MCC) gene is upregulated in glioblastoma, promoting cell proliferation and migration. High MCC expression correlates with poor prognosis in glioblastoma patients, suggesting its role in tumor progression.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- The mutated in colorectal cancer (MCC) gene, a known regulator of cell cycle, has unexplored roles in brain tumors.
- Glioblastoma is an aggressive brain tumor with limited treatment options.
Purpose Of The Study
- To investigate the role and expression of the MCC gene in glioblastoma.
- To determine the association between MCC expression and glioblastoma patient prognosis.
Main Methods
- MCC expression analysis in glioblastoma cell lines, patient samples, and public databases (TCGA, CGGA, GTEx).
- MCC gene knockdown using siRNA to assess effects on cell proliferation and migration.
- Analysis of MCC protein and mRNA levels.
- Investigation of MCC subcellular localization.
Main Results
- MCC expression is elevated in glioblastoma cell lines and tumors compared to normal brain tissue.
- MCC gene silencing increases glioblastoma cell proliferation and migration.
- High MCC expression is linked to poorer prognosis in glioblastoma patients.
- MCC exhibits nuclear localization in glioblastoma cells.
Conclusions
- MCC is significantly upregulated in glioblastoma and contributes to its pathophysiology.
- MCC may serve as a prognostic biomarker for glioblastoma.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...